Advertisement

[-2]pro-Prostataspezifisches Antigen

  • S. HoldenriederEmail author
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Boegemann M et al (2016) The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years. BJU Int 117:72–79CrossRefPubMedPubMedCentralGoogle Scholar
  2. Jansen FH et al (2010) Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection. Eur Urol 57:921–927CrossRefPubMedPubMedCentralGoogle Scholar
  3. Sokoll LJ et al (2010) A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomark Prev 19:1193–1200CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für LaboratoriumsmedizinDeutsches Herzzentrum München, Klinik an der Technischen Universität MünchenMünchenDeutschland

Personalised recommendations